CABINET DE MEDECINE GENERALE PAUL KELCHTERMANS
0821.738.072 · rovalta.com · 27/09/2026
NORMAL SITUATION
CABINET DE MEDECINE GENERALE PAUL KELCHTERMANS
Company — Normal situation.
Financial year 2023 · Closed on 31/12/2023
Net result43,6 k €-22,9 %over 1 year
Gross margin67,6 k €-23,0 %over 1 year
Equity565,6 k €+8,4 %over 1 year
Overview
Identity
Source · BCE/KBOCABINET DE MEDECINE GENERALE PAUL KELCHTERMANS is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0821.738.072
- Legal form
- Private company with limited liability
- Contributed capital
- 69 550,00 €
- Latest accounts
- 31/12/2023
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 15 filingsTrend over 14 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 67,6 k € | -23.0% | 87,8 k € | -43.8% | 156,1 k € | +28.2% | 121,7 k € | +15.8% | 105,2 k € |
| EBITDA | 62,8 k € | -27.4% | 86,6 k € | -42.5% | 150,6 k € | +45.4% | 103,6 k € | +15.5% | 89,7 k € |
| Operating result | 61,3 k € | -25.6% | 82,3 k € | -44.4% | 148,1 k € | +45.8% | 101,6 k € | +78.7% | 56,8 k € |
| Net result | 43,6 k € | -22.9% | 56,6 k € | -45.8% | 104,4 k € | +31.9% | 79,2 k € | +98.1% | 40 k € |
| Balance sheet | |||||||||
| Equity | 565,6 k € | +8.4% | 522 k € | +12.2% | 465,4 k € | +28.9% | 361 k € | +28.1% | 281,8 k € |
| Total assets | 577 k € | +0.5% | 574,3 k € | +9.5% | 524,5 k € | +31.0% | 400,5 k € | +34.1% | 298,7 k € |
| Cash | 546,9 k € | -2.3% | 559,5 k € | +9.6% | 510,7 k € | +31.5% | 388,3 k € | +39.1% | 279,2 k € |
| Debts | 11,3 k € | -78.1% | 51,7 k € | +16.5% | 44,4 k € | +12.5% | 39,5 k € | +134% | 16,9 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20231 active · 2 ended
Active mandates
Paul Kelchtermans
ActiveEnded mandates
Paul Kelchtermans
EndedPaul Kelchtermans
EndedFinancials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 10/06/2024 | 01/09/2023 | 31/08/2022 | 31/08/2021 | 09/11/2020 | 28/08/2019 |
| General meeting | 08/06/2024 | 06/08/2023 | 30/06/2022 | 30/06/2021 | 08/09/2020 | 30/06/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2023 | 08/06/2024 | 10/06/2024 | French | |
| Micro model | 31/12/2022 | 06/08/2023 | 01/09/2023 | French | |
| Micro model | 31/12/2021 | 30/06/2022 | 31/08/2022 | French | |
| Micro model | 31/12/2020 | 30/06/2021 | 31/08/2021 | French | |
| Micro model | 31/12/2019 | 08/09/2020 | 09/11/2020 | French | |
| Micro model | 31/12/2018 | 30/06/2019 | 28/08/2019 | French | |
| Micro model | 31/12/2017 | 30/06/2018 | 31/08/2018 | French | |
| Abridged model | 31/12/2016 | 08/08/2017 | 08/08/2017 | French | |
| Abridged model | 31/12/2015 | 18/08/2016 | 22/08/2016 | French | |
| Abridged modelCorrection | 31/12/2014 | 28/08/2015 | 18/03/2016 | French | |
| Abridged model | 31/12/2014 | 28/08/2015 | 31/08/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 29/08/2014 | French | |
| Abridged model | 31/12/2012 | 08/06/2013 | 25/07/2013 | French | |
| Abridged model | 31/12/2011 | 30/06/2012 | 08/08/2012 | French | |
| Abridged model | 31/12/2010 | 30/06/2011 | 02/08/2011 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active · 2 ended
Active mandates
Paul Kelchtermans
ActiveEnded mandates
Paul Kelchtermans
EndedPaul Kelchtermans
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution30/01/2025RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
- Mandates28/03/2014CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Capital / shares29/01/2010CAPITAL, ACTIONS
- Other05/01/2010RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 202343,6 k €↓
- 2022Annual accounts 202256,6 k €↓
- 2022Name changeCABINET DE MEDECINE MEDICAL PAUL
- 2021Annual accounts 2021104,4 k €↑
- 2021Name changeCABINET DE MEDECINE GENERALE PAUL KELCHTERMANS
- 2020Annual accounts 202079,2 k €↑
- 2019Annual accounts 201940 k €↑
- 2018Annual accounts 201825,1 k €↑
- 2017Annual accounts 2017-27,1 k €↓
- 2016Annual accounts 201627,2 k €↓
- 2015Annual accounts 201536,8 k €↓
- 2014Annual accounts 201445,1 k €↑
- 2013Annual accounts 201327,7 k €↓
- 2012Annual accounts 201235,4 k €↑
- 2011Annual accounts 201134,3 k €↑
- 2010Annual accounts 201031,3 k €